Pages • 2
Merck&Company Essay Preview: Merck&Company Report this essay Main Issue In 2000, Rich Kender, Vice President of Financial Evaluation and Analysis at Merck & Company was discussing the opportunity of investing in licensing, manufacturing and marketing of Davanrik, a drug originally developed to treat depression by LAB Pharmaceuticals. LAB proposed to sell the right of all.
Related Essay Topics:
Decision TreeResults Of Decision TreeRich KenderVice President Of Financial Evaluation